Please join us on 30 September at the MRC Clinical Trials Unit to discuss the role of fluoroquinolones in TB treatment and the results of the REMoxTB Study.
Presenter: Patrick Phillips
Paper: Gillespie et al. Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis. N Engl J Med 2014, published online ahead of print. Available here.
Time: 1230 til 1330 on Tuesday 30 September.
Venue: Rooms 2 and 3, 4th floor, MRC CTU. **Note room change**
Directions: See http://www.ctu.mrc.ac.uk/about_us/contact_details/. The entrance is opposite Holborn tube station and looks like the entrance to a church building.
External attendees will need to wait at reception and be taken to the meeting room. If you plan to attend, please contact Patrick Phillips (new email address – Patrick.email@example.com) so that reception know who is expected. Please also arrive promptly to ensure access to the building.